Volume | 184,148 |
|
|||||
News | - | ||||||
Day High | 20.753 | Low High |
|||||
Day Low | 19.97 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Fulgent Genetics Inc | FLGT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
20.65 | 19.97 | 20.753 | 20.03 | 20.74 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,854 | 184,148 | $ 20.18 | $ 3,715,709 | - | 19.88 - 44.09 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:13:53 | 1 | $ 20.15 | USD |
Fulgent Genetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
596.59M | 29.78M | - | 289.21M | -167.83M | -5.63 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Fulgent Genetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FLGT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.00 | 21.05 | 19.88 | 20.45 | 166,210 | 0.03 | 0.15% |
1 Month | 21.71 | 22.16 | 19.88 | 20.92 | 160,637 | -1.68 | -7.74% |
3 Months | 24.65 | 26.365 | 19.88 | 23.01 | 222,000 | -4.62 | -18.74% |
6 Months | 25.03 | 30.68 | 19.88 | 25.04 | 209,360 | -5.00 | -19.98% |
1 Year | 29.75 | 44.09 | 19.88 | 29.52 | 216,847 | -9.72 | -32.67% |
3 Years | 84.71 | 112.00 | 19.88 | 60.45 | 361,840 | -64.68 | -76.35% |
5 Years | 7.36 | 189.8899 | 4.712 | 59.69 | 509,447 | 12.67 | 172.15% |
Fulgent Genetics Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |